No brainer for BrainZ

By Dylan Bushell-Embling
Wednesday, 08 October, 2008

BrainZ Instruments [ASX: BZI] is to be acquired by the US-based Natus Medical for NZ$1.3 million [AUD$1.13 million].

Pending shareholder approval, Natus will acquire essentially every trading asset of BrainZ - including products, IP and brand – except the company's cash reserves.

If the arrangement goes ahead, Natus will assume a number of the company’s distribution and customer support obligations.

BrainZ has developed a bedside brain monitoring technology that assists in the detection of brain injury and seizure activity in neonates.

Content from other channels on our network

Cyber risk is rising faster than Australian manufacturers can respond

Fortescue commissions first battery electric locomotives

Electric actuation: a gamechanger for upstream processes

Government seeks input on wind and transmission infrastructure

Additive manufacturing unlocks power for space and defence missions

Liquid metal to 'harvest' clean hydrogen from water

Epson makes progress with sustainability plans and initiatives in Australia and New Zealand

Sustainable wastewater treatment achieved for urban areas

'Brownfielding' increases to meet metal demand

NSW to exceed energy storage targets

Health Star Ratings set to become regulated in Australia and NZ

Fast detection of food contamination using enhanced AI tool

Abattoir safety program in WA raises more awareness

Closing the loop with food packaging made from fish skin waste

Electric trucks hit the road to deliver beer in Perth

No brainer for BrainZ

Noxopharm says paper reveals science behind its immune system platform

Neurosensing/neurostimulation implants session to be held on Monday

argenx and Monash University partner against autoimmune diseases

Content from other channels on our network